Crawford Lake Capital Management’s Altimmune ALT Stock Holding History

Crawford Lake Capital Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-29,130	Closed	-$385K	–	52
2020 Q3	$385K	Buy	+29,130	New	+$582K	0.16%	56

Other funds holding ALT

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Crawford Lake Capital Management's ALT Position: Q4 2020 in Review

Crawford Lake Capital Management sold out of Altimmune (ALT) in Q4 2020, closing a stake of 29,130 shares — an estimated $385K sold.

Crawford Lake Capital Management first reported a position in ALT in Q3 2020 and held it in 1 quarter. The position peaked at $385K in Q3 2020. 88 funds tracked by Wall St. Rank hold ALT as of Q4 2020.

Crawford Lake Capital Management reported no remaining Altimmune position as of Q4 2020 after selling out during the quarter.
Crawford Lake Capital Management sold 29,130 Altimmune shares in Q4 2020, an estimated $385K.
Crawford Lake Capital Management first reported a position in Altimmune in Q3 2020 and held it in 1 quarter.
Crawford Lake Capital Management's Altimmune position peaked at $385K in Q3 2020.
88 funds tracked by Wall St. Rank held Altimmune as of Q4 2020.

Based on Crawford Lake Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.